Prostaglandins: What are they and how do they work?

Prostaglandins: What are they and how do they work?

A prostaglandin is any member of a group of lipid compounds that are derived enzymatically from fatty acids and have important functions in the animal body. Every prostaglandin contains 20 carbon atoms, including a 5-carbon ring.


They are mediators and have a variety of strong physiological effects, such as regulating the contraction and relaxation of smooth muscle tissue. Prostaglandins are not hormones, but autocrine or paracrine, which are locally acting messenger molecules. They differ from hormones in that they are not produced at a discrete site but in many places throughout the human body. Also, their target cells are present in the immediate vicinity of the site of their secretion (of which there are many).

The prostaglandins, together with the thromboxanes and prostacyclins, form the prostanoid class of fatty acid derivatives, a subclass of eicosanoids.

Looking to buy prostaglandin products for research and development purposes? See LGM Pharma’s Prostaglandin products listed below:

Product Name: CAS#:
Alfaprostol 74176-31-1
Alprostadil  745-65-3
Beraprost Sodium 88475-69-8
Bimatoprost 155206-00-1
Carboprost 35700-23-3
Carboprost Tromethamine 58551-69-2
Cloprostenol 40665-92-7
Cloprostenol Sodium 55028-72-3
Dinoprost Tromethamine Salt 38562-01-5
Dinoprost  551-11-1
Dinoprostone 363-24-6
Epoprostenol Sodium 61849-14-7
Iloprost 73873-87-7
Latanoprost 130209-82-4
Limaprost Alfadex 88852-12-4
Lubiprostone 136790-76-6
Luprostiol 67110-79-6
Misoprostol 59122-46-2
Tafluprost 209860-87-7
Tiaprost 71116-82-0
Travoprost 157283-68-6
Treprostinil Sodium 289480-64-4
Unoprostone 120373-36-6
Unoprostone Isopropyl Ester 120373-24-2
Prostaglandin intermediates :
D-Corey lactone 76704-05-7
L-Corey lactone 32233-40-2
Corey Lactone 4-Phenylbenzoate 31752-99-5
Corey Lactone Benzoate 39746-00-4
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.
  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service